167 related articles for article (PubMed ID: 32352723)
1. Distinctive Features and Outcomes of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Disease: A US Multicenter Study.
deLemos A; Patel M; Gawrieh S; Burney H; Dakhoul L; Miller E; Scanga A; Kettler C; Liu H; Roche P; Wattacheril J; Chalasani N
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00139. PubMed ID: 32352723
[TBL] [Abstract][Full Text] [Related]
2. Alcoholic Liver Disease-Related Hepatocellular Carcinoma: Characteristics and Comparison to General Slovak Hepatocellular Cancer Population.
Šafčák D; Dražilová S; Gazda J; Andrašina I; Adamcová-Selčanová S; Barila R; Mego M; Rác M; Skladaný Ľ; Žigrai M; Janičko M; Jarčuška P
Curr Oncol; 2023 Mar; 30(3):3557-3570. PubMed ID: 36975484
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey.
Tokushige K; Hyogo H; Nakajima T; Ono M; Kawaguchi T; Honda K; Eguchi Y; Nozaki Y; Kawanaka M; Tanaka S; Imajo K; Sumida Y; Kamada Y; Fujii H; Suzuki Y; Kogiso T; Karino Y; Munekage K; Kuromatsu R; Oeda S; Yanase M; Mori K; Ogawa Y; Seko Y; Takehara T; Itoh Y; Nakajima A; Kanemasa K; Nishino K; Masaki N; Takahashi H; Seike M; Torimura T; Saibara T; Toyota J; Chayama K; Hashimoto E
J Gastroenterol; 2016 Jun; 51(6):586-96. PubMed ID: 26456168
[TBL] [Abstract][Full Text] [Related]
4. Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
Ahn SY; Kim SB; Song IH
Can J Gastroenterol Hepatol; 2020; 2020():4873875. PubMed ID: 32566546
[TBL] [Abstract][Full Text] [Related]
5. Steatotic and Steatohepatitic Hepatocellular Carcinomas: Features in a Series With Predominantly Viral Etiology.
Aykutlu U; Argon A; Orman M; Ulukaya S; Zeytunlu M; Karasu Z; Günşar F; Nart D; Akarca U; Yilmaz F
Am J Surg Pathol; 2021 Sep; 45(9):1252-1263. PubMed ID: 33826548
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.
Tateishi R; Okanoue T; Fujiwara N; Okita K; Kiyosawa K; Omata M; Kumada H; Hayashi N; Koike K
J Gastroenterol; 2015 Mar; 50(3):350-60. PubMed ID: 24929638
[TBL] [Abstract][Full Text] [Related]
7. Comparative Analysis of Nonalcoholic Steatohepatitis- Versus Viral Hepatitis- and Alcohol-Related Liver Disease-Related Hepatocellular Carcinoma.
Hester CA; Rich NE; Singal AG; Yopp AC
J Natl Compr Canc Netw; 2019 Apr; 17(4):322-329. PubMed ID: 30959469
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
[TBL] [Abstract][Full Text] [Related]
9. Gender Matters: Characteristics of Hepatocellular Carcinoma in Women From a Large, Multicenter Study in the United States.
Phipps M; Livanos A; Guo A; Pomenti S; Yeh J; Dakhoul L; Burney H; Kettler C; Liu H; Miller E; Gawrieh S; deLemos A; Scanga A; Chalasani N; Wattacheril J
Am J Gastroenterol; 2020 Sep; 115(9):1486-1495. PubMed ID: 32453046
[TBL] [Abstract][Full Text] [Related]
10. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
[TBL] [Abstract][Full Text] [Related]
11. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study.
Costentin CE; Mourad A; Lahmek P; Causse X; Pariente A; Hagège H; Dobrin AS; Becker C; Marks B; Bader R; Condat B; Héluwaert F; Seitz JF; Lesgourgues B; Denis J; Deuffic-Burban S; Rosa I; Decaens T;
Cancer; 2018 May; 124(9):1964-1972. PubMed ID: 29589878
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of non-B non-C hepatocellular carcinoma: a single-center retrospective study.
Kim SK; Marusawa H; Eso Y; Nishikawa H; Ueda Y; Kita R; Kimura T; Chiba T; Osaki Y; Kudo M
Digestion; 2011; 84 Suppl 1():43-9. PubMed ID: 22156485
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting.
Said A; Williams J; Holden J; Remington P; Musat A; Lucey MR
Clin Gastroenterol Hepatol; 2004 Oct; 2(10):928-34. PubMed ID: 15476157
[TBL] [Abstract][Full Text] [Related]
15. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
Ioannou GN; Green P; Kerr KF; Berry K
J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
[TBL] [Abstract][Full Text] [Related]
16. Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study.
Gawrieh S; Dakhoul L; Miller E; Scanga A; deLemos A; Kettler C; Burney H; Liu H; Abu-Sbeih H; Chalasani N; Wattacheril J
Aliment Pharmacol Ther; 2019 Oct; 50(7):809-821. PubMed ID: 31475372
[TBL] [Abstract][Full Text] [Related]
17. Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis.
Hashimoto E; Taniai M; Kaneda H; Tokushige K; Hasegawa K; Okuda H; Shiratori K; Takasaki K
Alcohol Clin Exp Res; 2004 Aug; 28(8 Suppl Proceedings):164S-168S. PubMed ID: 15318106
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States.
Younossi ZM; Stepanova M; Ong J; Trimble G; AlQahtani S; Younossi I; Ahmed A; Racila A; Henry L
Clin Gastroenterol Hepatol; 2021 Mar; 19(3):580-589.e5. PubMed ID: 32531342
[TBL] [Abstract][Full Text] [Related]
19. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
[TBL] [Abstract][Full Text] [Related]
20. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
